{"id":"W4403831401","doi":"10.1681/asn.2024c9ebnjqe","title":"NeflgArd Open-Label Extension: Efficacy and Safety of Nefecon in Patients with IgAN Who Completed the 2-Year Phase 3 Trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Open label; Medicine; Extension (predicate logic); Internal medicine; Clinical trial; Intensive care medicine; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002124562,0.0006278472,0.001104597,0.0001731491,0.0003177562,0.0008939723,0.0006138216,0.001071458,0.006635026],"category_scores_gemma":[0.001445248,0.0002146592,0.001052507,0.0001638092,0.0004824598,0.0009569775,0.0003418406,0.002009792,0.0008885358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000733126,"about_ca_system_score_gemma":0.001009787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005388873,"about_ca_topic_score_gemma":0.002271268,"domain_scores_codex":[0.9995783,0.0002123881,0.00002427678,0.00005453656,0.00005202357,0.0000783519],"domain_scores_gemma":[0.9990701,0.0002223302,0.0002299041,0.00008627318,0.00009846497,0.0002929166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9082828,0.01434449,0.006000128,0.0008877336,0.000811342,0.0001887779,0.0001430455,0.0006733263,0.007185689,0.0003226037,0.006117128,0.05504296],"study_design_scores_gemma":[0.8365148,0.133967,0.01998851,0.0001122144,0.000418359,0.0002987933,0.00005055962,0.0008750831,0.001263242,0.000336795,0.006144512,0.00003019369],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794495,0.004559635,0.0005953919,0.0009731489,0.0002133705,0.002575926,0.003867987,0.0001150953,0.00764992],"genre_scores_gemma":[0.9850049,0.001331426,0.00120341,0.001528186,0.0002122163,0.002213539,0.004553527,0.00001793936,0.003934955],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006635026,"threshold_uncertainty_score":0.02219641,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01826898132791963,"score_gpt":0.2822031869615203,"score_spread":0.2639342056336006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}